Facilities Engineer: Alexion Pharmaceuticals,Inc.
| Job ID | EB 090902 |
|---|
| Company Name | Alexion Pharmaceuticals,Inc. |
|---|
| Job Category | Engineering; Pharmaceutical/Biotech |
|---|
| Location | Smithfield, RI |
|---|
| Position Type | Full-Time, Employee |
|---|
| Experience | 5-10 Years Experience |
|---|
| Date Posted | September 8, 2009 (Reposted Nov 19) |
|---|
| View Alexion Pharmaceuticals,Inc. profile and job listings |
 |  Learn more about Alexion Pharmaceuticals, Inc. View All Alexion Pharmaceuticals, Inc. Opportunities |
| About Us:
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Employing more than 500 people worldwide, Alexion is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic and kidney diseases, transplant, cancer, and autoimmune disorders. Soliris (eculizumab) is Alexion's first marketed product for patients with paroxysmal nocturnal hemoglobinuria (PNH) a rare, debilitating and life-threatening blood disorder defined by the destruction of red blood cells, or hemolysis. Soliris is approved in the U.S. and Europe in 2007, and Canada and Australia in 2009. Alexion is evaluating other potential indications for Soliris as well as other formulations of eculizumab for additional clinical indications, and is pursuing development of other antibody product candidates in early stages of development. Further information about Alexion Pharmaceuticals, Inc. can be found at: www.alexionpharma.com.Responsiblities: - The Engineer will be responsible for all engineering duties related to a biotechnical manufacturing facility. The Engineer will be responsible for small projects, vendor inquires and troubleshooting of process and utilities equipment.
- The Engineer will participate on capital project teams through all phases of projects. These phases will include conceptual design, detailed design, equipment procurement, construction, installation; start up, commissioning, validation and qualification.
- Provides support to manufacturing and maintenance where required. Ensures that new equipment is included in the plant maintenance and calibration program, ensures critical spare parts are readily available.
- Plans and manages semi-annual maintenance shutdown activities. Oversees upgrades, ensures completion of preventative maintenance activities in accordance with shut down plan.
- Performs investigations relating to equipment malfunctions.
Requirements - Experience in troubleshooting and providing technical support for cGMP manufacturing, equipment, utilities and HVAC systems in a biological or aseptic processing environment.
- Experience with sanitary design of piping and manufacturing equipment.
- Experience in working with equipment manufacturers and developing preventative maintenance procedures for cGMP manufacturing equipment.
- Must have good interpersonal skills and be able to communicate well, both verbally and written.
- The individual in this position is expected to represent Alexion Pharmaceuticals interests, objectives and policies in a professional and responsible manner.
- Must have the ability to manage outside service providers.
- Education and experience: BS in mechanical or chemical engineering. A minimum of 5-7 years relevant experience in cGMP environment is desirable.
About Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Employing more than 500 people worldwide, Alexion is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide array of severe disease states, including hematologic and kidney diseases, transplant, cancer, and autoimmune disorders. Soliris(R) (eculizumab) is Alexion's first marketed product for patients with paroxysmal noctural hemoglobinuria (PNH) a rare, debilitating and life-threatening blood disorder defined by the destruction of red blood cells, or hemolysis. Soliris is approved in the U.S. and Europe in 2007, and Canada and Australia in 2009. Alexion is evaluating other potential indications for Soliris as well as other formulations of eculizumab for additional clinical indications, and is pursuing development of other antibody product candidates in early stages of development.
Alexion offers a highly competitive package of base and incentive compensation, group healthcare coverage, tuition reimbursement, relocation assistance, and a 401(K) plan.
Alexion is an Equal Opportunity/Affirmative Action Employer. |
|
|
|
